 increase
in their costs ($33,907). Those patients who had recurrence of their VLU (N Â¼ 17; 20%) during the follow-up
period had a total mean cost of $12,760. Inpatient admission, of which nearly two thirds was for treatment of infections that were resistant to therapy in an outpatient setting,
markedly increased costs ($33,629). By contrast, VLU
treated with surgical